NCT Number: NCT00563199
A Randomized Controlled Trial of a Nurse Delivered Stage-matched Smoking Cessation Intervention to Promote Heart Health of Cardiac Patients
This study is a randomized controlled trial designed to evaluate the effectiveness of a nurse delivered stage-matched intervention to cardiac patients for cessation of tobacco use. Review of literature shows that there is a clear lack of empirical evidence on (1) using nurses to deliver stage-matched smoking cessation interventions, and (2) the effectiveness of such intervention for cardiac patients in Chinese populations. The ultimate goal of the intervention achieve a higher quit rate in the intervention group than in the controls. In addition, the change in the patient's smoking behaviour such as reduction of the number of cigarettes smoked, and progression to a higher stage of readiness to quit, will also be measured. This study is the first step to address the urgently needed data for (1) promoting the delivery of nurse-run stage-matched smoking cessation interventions to help patients stop smoking, (2) developing smoking cessation policy and programmes in the hospitals and for the health care system, and (3) contributing an evidence-based approach to orientate clinical services towards prevention, so as to reduce premature deaths and the enormous disease burden of our society.
Looking for future studies?
Notify MeKey information
Conditions
Sex eligibility
All sexes
Study type
Interventional
Phase
Not applicable
Primary location
Caritas Medical Centre, Hong Kong, China
Who can participate
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Patient who is admitted to the participating centres and is a current smoker who has smoked daily in the past 7 days prior to hospitalization.
- Patient speaks and reads Cantonese/Chinese
Exclusion criteria
- Patient who is clinically too ill and not suitable to complete questionnaire and/or receive intervention.
- Patient who does not speak or read Chinese
Treatment and study plan
Primary outcomes
-
Quitting--to achieve higher quit rate in the cardiac patients (coronary artery disease) who are smokers
Time frame: continuous abstinence for one month at the time of 3, 6 and 12 month follow up
Secondary outcomes
-
Reduction of the number of cigarettes smoked
Time frame: at the time of 3, 6 and 12 month follow up
-
Progression to a higher stage of readiness to quit
Time frame: at the time of 3, 6 and 12 month follow up
Sponsors and collaborators
Lead sponsor
Hospital Authority, Hong Kong
Other Gov
Collaborators
- Research Grants Council, Hong Kong
Registry information
Important dates
- Study start
- 2002
- Study completion
- 2005
- First posted
- Nov 26, 2007
- Registry last updated
- Jun 16, 2011
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Translational Research Center in Lung Cancer Disparities (TRACER) Project 2
NCT05490251
Behavior, Fractures, Bone
Los Angeles, California, United States
View Trial DetailsBAPS in Botswana: The Thotloetso Trial
NCT04532970
Behavior, Blood-Borne Infections
Gaborone, Botswana
View Trial DetailsImproving the Reach & Effectiveness of Smoking Cessation Services Targeted to Veterans Living With HIV
NCT04505371
Behavior, Blood-Borne Infections
Seattle, Washington, United States
View Trial DetailsTreating Caregivers Who Smoke at AFCH
NCT06051474
Behavior, Health Behavior
Madison, Wisconsin, United States
View Trial Details